rediff.com

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Sign in  |  Create a Rediffmail account
Rediff News  All News 

Ranbaxy Laboratories Ltd

Subscribe via RSS
Rediff.com  »  News  »   Ranbaxy Laboratories Ltd

  News for Ranbaxy Laboratories Ltd

  • Business

Ranbaxy may reduce global sales team

 Even as trouble thickens for drug maker Ranbaxy Laboratories, the company is now considering downsizing its global sales force by around a third.A majority of the job cuts would be in the US, it is......

Daiichi pursuing legal action on ex-shareholders

 Daiichi Sankyo, the Japanese parent of Ranbaxy Laboratories, said on Wednesday it believed certain former shareholders of the Indian company had concealed critical information.It was now pursuing......

Ranbaxy 'systematically violated' norms: Whistleblower

Ranbaxy Laboratories "systemically violated" good manufacturing practices, says the whisteblower whose alert led to a US probe, a day after India's top drugmaker agreed to pay a hefty $500 million......

Ranbaxy to pay $500 mn to settle US fraud charges

 The country’s biggest drugmaker, Ranbaxy Laboratories on Monday agreed to pay $500 million (around Rs 2,743 crore) to resolve fraud allegations made in a whistle-blower’s lawsuit and......

Ranbaxy resumes supply of Atorvastatin tablets in US

 Drug major Ranbaxy Laboratories said on Monday it has resumed the supply of Atorvastatin calcium tablets, a cholesterol lowering drug, in the US market."Ranbaxy Pharmaceuticals Inc, the US......

  People speak for ranbaxy laboratories ltd

  • QNA
Q. What after B. Tech?
:  A. After B.Tech you can choose your career in the filed of Intellectual Property Rights. Jobs in patent law can be an interesting career option for...... more

http://qna.rediff.com/questions-and-answers/what-after-b.-tech//answers/17277900

Sunil
Q. Can some one give me the list of shares in NIFTY, with maximum dividend yield
Sunil:  A. ABB Ltd.,ELECTRICAL EQUIPMENT,ABB,EQ,INE117A01022ACC Ltd.,CEMENT AND CEMENT PRODUCTS,ACC,EQ,INE012A01025Ambuja Cements Ltd.,CEMENT AND CEMENT...... more

http://qna.rediff.com/questions-and-answers/can-some-one-give-me-the-list-of-shares-in-nifty-with-maximu/17277785/answers/17134838

CK Murty
Q. what is the level we can buy this Ranbaxy Laboratories Ltd. stock for long term
CK Murty:  A. Buy at @150-160 for long term investment. more

http://qna.rediff.com/questions-and-answers/what-is-the-level-we-can-buy-this-ranbaxy-laboratories-ltd.-/14529285/answers/14210606

Deepak Chaudhary
Q. shall i buy Ranbaxy Laboratories Ltd at current price at 176rs
Deepak Chaudhary:  A. Yeah sure... its good buying more

http://qna.rediff.com/questions-and-answers/shall-i-buy-ranbaxy-laboratories-ltd-at-current-price-at-176/14209671/answers/13353089

dhamu
Q. how do they calculate sensex and nifty??
Dhamu :  A. Sensex List is : ACC LTD BHARTI AIRTEL LTD BHEL LTD CIPLA LTD DLF LTD GRASIM LTD HDFC HDFC BANK LTD HINDALCO INDUSTRIES LTD ICICI BANK LTD INFOSYS...... more

http://qna.rediff.com/questions-and-answers/how-do-they-calculate-sensex-and-nifty/13352699/answers/11270416

  Web results for Ranbaxy Laboratories Ltd
No impact of Ranbaxy crisis on drug sale

Even as the corporate world is abuzz with the controversy around Ranbaxy Laboratories, people on the ground such as chemists and pharmacists... ...

http://www.business-standard.com/article/companies/no-impact-of-ranbaxy-crisis-on-drug-sale-113052400910_1.html
It was perhaps too late for Daiichi to exit Ranbaxy after USFDA action

India News: Although the deal was concluded in November 2008, two months after a USFDA action, it was perhaps too late for Daiichi to exit.... ...

http://www.keralanext.com/news/2013/05/24/article171.asp
Malvinder Singh lashes out at Daiichi Sankyo, says 'They didn't run Ranbaxy Laboratories Limited well, now they blame me'

nbaxy Laboratories Limited promoter, CEO and MD, Malvinder Singh on Thursday lashed out at Daiichi Sankyo, saying the Japanese drug major was... ...

http://www.financialexpress.com/news/malvinder-singh-lashes-out-at-daiichi-sankyo-says-they-didnt-run-ranbaxy-laboratories-limited-well-now-they-blame-me/1119915/
Daiichi's allegations are baseless

Malvinder Singh, the former owner of Ranbaxy Laboratories, finds himself in the centre of a storm. Daiichi Sankyo, the Indian drug maker's current... ...

http://economictimes.indiatimes.com/opinion/interviews/daiichis-allegations-are-baseless-malvinder-singh/articleshow/20235327.cms
Indian pharma under the microscope

US FDA issues import alert on Wockhardt plant; drug makers fear being smeared by the transgressions of a few Vidya Krishnan | C.H. Unnikrishnan A... ...

http://www.livemint.com/Industry/nTIfqyG87wxdlz8txCa6HL/Indian-pharma-under-the-microscope.html
See All

Related Tags

  1. ranbaxy
  2. bse
  3. india
  4. mohali
  5. us food and drug administration
  6. new brunswick
  7. new jersey
  8. smc global securities
  9. fy14
  10. wipro ltd
  11. new delhi
  12. fy13
  13. jp morgan
  14. united states
  15. phani sekhar
  16. infosys ltd
  17. viju george
  18. tata consultancy services ltd
  19. jagannadham thunuguntla
  20. shibulal
  21. larsen & toubro ltd
  22. angel broking in mumbai
  23. vikas khemani
  24. national stock exchange
  25. hcl technologies ltd
  26. anshuman atri of espirito santo securities
  27. sharekhan equity advisory team
  28. karnataka
  29. jindal steel and power ltd
  30. tata power co ltd

Top Coverage News

Indian Premier League - IPL 2013

Coverage: The Match-Fixing Episode II - spot-fixing trial

 Coverage of the match-fixing episode involving the Pakistan cricket team in England.

Sachin Tendulkar : Cup of praise overfloweth - Reactions

Complete coverage of Mumbai blasts

 Three blasts rocked Mumbai's crowded Zaveri Bazar, Opera House and Dadar Kabootarkhana areas on...

Decoding India’s Corruption Wars - Ajit Balakrishnan's Blog
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
rediff on the net© 2013 Rediff.com - Investors - Advertise - Disclaimer - Privacy - Careers - Feedback | Terms of use | India Abroad weekly